Internal Medicine · Andalusia, AL
NPI
1417148081
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1212 E Three Notch St
Andalusia, AL, 36420
Phone (334) 222-6041
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
2,223 services
Medicare patients, 2024
319
Average age 73
Drug cost, 2024
$1.5M
16,384 prescriptions
Company payments, 2025
$60.81
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yongkuma C Yongkuma was code 99214 (office e&m - established), 500 times for 169 patients. In total Yongkuma C Yongkuma billed 2,223 services in 47 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 500 | 169 | $79.14 | $40K |
| 99233 Hospital E&M - Subsequent | Facility | 306 | 91 | $90.12 | $28K |
| 82962 Clinical Chemistry | Office | 220 | 65 | $3.14 | $690 |
| 99215 Office E&M - Established | Office | 206 | 137 | $122.14 | $25K |
| 80305 Drug Tests | Office | 178 | 32 | $12.35 | $2,198 |
| 99223 Hospital E&M - Initial | Facility | 154 | 125 | $130.82 | $20K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 110 | 110 | $117.60 | $13K |
| 96372 Injection Administration | Office | 73 | 22 | $9.54 | $697 |
| 99238 Hospital Discharge Management | Facility | 52 | 43 | $61.40 | $3,193 |
| G0008 Administration of influenza virus vaccine | Office | 44 | 43 | $27.44 | $1,207 |
| 99213 Office E&M - Established | Office | 43 | 27 | $41.74 | $1,795 |
| 90653 Vaccine Product | Office | 39 | 39 | $81.82 | $3,191 |
| 99239 Hospital Discharge Management | Facility | 37 | 35 | $88.84 | $3,287 |
| 81003 Clinical Chemistry | Office | 33 | 25 | $2.20 | $72.6 |
| 99204 Office E&M - New | Office | 20 | 20 | $102.92 | $2,058 |
By year: 2022 $188K for 3,629 services; 2023 $158K for 3,176 services; 2024 $154K for 2,223 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 220 | 65 | $3.14 | $690 |
| 80305 Drug Tests | 178 | 32 | $12.35 | $2,198 |
| 81003 Clinical Chemistry | 33 | 25 | $2.20 | $72.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Yongkuma C Yongkuma prescribed most often to Medicare patients was Atorvastatin Calcium, with 470 prescriptions and refills. In total Yongkuma C Yongkuma wrote 16,384 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 470 | 1,231 | 142 | $5,159 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 467 | 467 | 46 | $8,273 |
| Potassium Chloride Generic | 435 | 1,059 | 123 | $6,478 |
| Omeprazole Generic | 432 | 1,098 | 119 | $7,170 |
| Levothyroxine Sodium Generic | 393 | 926 | 91 | $3,626 |
| Buspirone Hcl Generic | 383 | 720 | 95 | $7,366 |
| Furosemide Generic | 376 | 956 | 111 | $1,870 |
| Montelukast Sodium Generic | 338 | 812 | 93 | $3,624 |
| Trazodone Hcl Generic | 320 | 816 | 92 | $2,557 |
| Tizanidine Hcl Generic | 307 | 412 | 67 | $3,820 |
| Pantoprazole Sodium Generic | 299 | 840 | 98 | $2,876 |
| Tramadol Hcl Generic | 298 | 298 | 39 | $2,348 |
| Losartan Potassium Generic | 296 | 841 | 95 | $2,980 |
| Lisinopril Generic | 294 | 833 | 94 | $1,975 |
| Amlodipine Besylate Generic | 282 | 786 | 87 | $1,734 |
Brand drugs: 1,805 claims; generic drugs: 14,431 claims; opioid claims: 947.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yongkuma C Yongkuma $60.81 ($60.81 in general payments such as food, travel and fees) from 3 companies. The largest payer was Merck Sharp & Dohme LLC with $23.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.